REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $207,412 | -47.0% | 18,083 | +17.0% | 0.00% | -50.0% |
Q2 2023 | $391,318 | -15.2% | 15,461 | +7.9% | 0.00% | 0.0% |
Q1 2023 | $461,473 | +80.2% | 14,327 | +3.3% | 0.00% | +100.0% |
Q4 2022 | $256,059 | +20.2% | 13,871 | +76.0% | 0.00% | 0.0% |
Q3 2022 | $213,000 | +95.4% | 7,882 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $109,000 | -29.2% | 7,882 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $154,000 | +19.4% | 7,882 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $129,000 | -41.4% | 7,882 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $220,000 | -6.0% | 7,882 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $234,000 | +6.4% | 7,882 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $220,000 | -1.3% | 7,882 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $223,000 | +12.6% | 7,882 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $198,000 | +3.1% | 7,882 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $192,000 | +242.9% | 7,882 | +107.0% | 0.00% | +100.0% |
Q1 2020 | $56,000 | +27.3% | 3,807 | +39.6% | 0.00% | – |
Q4 2019 | $44,000 | +25.7% | 2,727 | 0.0% | 0.00% | – |
Q3 2019 | $35,000 | +84.2% | 2,727 | +86.1% | 0.00% | – |
Q2 2019 | $19,000 | -17.4% | 1,465 | 0.0% | 0.00% | – |
Q1 2019 | $23,000 | -51.1% | 1,465 | -37.7% | 0.00% | – |
Q4 2018 | $47,000 | +56.7% | 2,352 | +97.2% | 0.00% | – |
Q3 2018 | $30,000 | -9.1% | 1,193 | 0.0% | 0.00% | – |
Q2 2018 | $33,000 | -10.8% | 1,193 | 0.0% | 0.00% | – |
Q1 2018 | $37,000 | -14.0% | 1,193 | 0.0% | 0.00% | – |
Q4 2017 | $43,000 | +330.0% | 1,193 | +213.9% | 0.00% | – |
Q3 2017 | $10,000 | 0.0% | 380 | 0.0% | 0.00% | – |
Q2 2017 | $10,000 | +25.0% | 380 | 0.0% | 0.00% | – |
Q1 2017 | $8,000 | 0.0% | 380 | 0.0% | 0.00% | – |
Q4 2016 | $8,000 | +33.3% | 380 | 0.0% | 0.00% | – |
Q3 2016 | $6,000 | +20.0% | 380 | 0.0% | 0.00% | – |
Q2 2016 | $5,000 | -28.6% | 380 | 0.0% | 0.00% | – |
Q1 2016 | $7,000 | -46.2% | 380 | 0.0% | 0.00% | – |
Q4 2015 | $13,000 | +18.2% | 380 | 0.0% | 0.00% | – |
Q3 2015 | $11,000 | -99.8% | 380 | -99.7% | 0.00% | -100.0% |
Q2 2014 | $4,420,000 | +40.3% | 130,000 | +30.0% | 0.13% | +34.0% |
Q1 2014 | $3,150,000 | – | 100,000 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |